Deadly disregard: government refusal to implement evidence-based measures to prevent HIV and hepatitis C virus infections in prisons

Elliott, Richard
July 2007
CMAJ: Canadian Medical Association Journal;7/31/2007, Vol. 177 Issue 3, p262
Academic Journal
The author comments on two studies from Ontario and Quebec which provide further proof of the need for action to reduce the prevalence of HIV and hepatitis C virus (HCV) infections in Canadian prisons. The studies support the earlier finding that the prevalence of both HIV and HCV infections is drastically higher among prisoners in Canada than in the general population. The studies also confirm the close relation between such infections and injection drug use.


Related Articles

  • Prevalence of HIV and hepatitis C virus infections among inmates of Quebec provincial prisons. Poulin, Céline; Alary, Michel; Lambert, Gilles; Godin, Gaston; Landry, Suzanne; Gagnon, Hélène; Demers, Éric; Morarescu, Elena; Rochefort, Jean; Claessens, Christiane // CMAJ: Canadian Medical Association Journal Supplement;7/31/2007, Vol. 177 Issue 3, p252 

    Background: To determine the prevalence of HIV and hepatitis C virus (HCV) infections and examine risk factors for these infections among inmates in Quebec provincial prisons. Methods: Anonymous cross-sectional data were collected from January to June 2003 for men (n= 1357) and women (n= 250)...

  • A SURVEY OF HIV AND HCV AMONG FEMALE PRISON INMATES IN PORTUGAL. Barros, Henrique; Ramos, Elisabete; Lucas, Raquel // Central European Journal of Public Health;2008, Vol. 16 Issue 3, p116 

    HIV and hepatitis C virus (HCV) monitoring among prison inmates is instrumental in countries with concentrated HIV/AIDS epidemics. Knowledge on these dynamics in imprisoned women in Portugal is scarce. The HIV and HCV prevalence was estimated among inmates in the largest Portuguese prison for...

  • Requiring Help Injecting as a Risk Factor for HIV Infection in the Vancouver Epidemic. Wood, Evan; Spittal, Patricia M.; Kerr, Thomas; Small, Will; Tyndall, Mark W.; O'Shaughnessy, Michael V.; Schechter, Martin T. // Canadian Journal of Public Health;Sep/Oct2003, Vol. 94 Issue 5, p355 

    Background: Requiring help injecting was recently associated with syringe sharing, and later HIV-1 and HCV seroconversion among injection drug users (IDU) in Vancouver. This risk factor remains poorly understood. The present study investigates this risk factor among Vancouver IDUs. Methods: We...

  • Retrospective cohort study examining incidence of HIV and hepatitis C infection among injecting drug users in Dublin. Smyth, B.P.; O'Connor, J.J.; Barry, J.; Keenan, E. // Journal of Epidemiology & Community Health;Apr2003, Vol. 57 Issue 4, p310 

    Analyzes a study of the cases of HIV and hepatitis C infections among intravenous drug abusers in Dublin, Ireland. Risk increase associated with drug addicts who share needles; Seroconversion rates.

  • Infection with HIV and hepatitis C virus among injecting drug users in a prevention... van Beek, Ingrid; Dwyer, Robyn; Done, Gregory J.; Kuo, Kehui; Kaldor, John M. // BMJ: British Medical Journal (International Edition);08/15/98, Vol. 317 Issue 7156, p433 

    Presents a study which was conducted to determine the incidence of human immunodeficiency virus (HIV) and hepatitis C virus infections among injecting drug users in Sydney, Australia. How the study was conducted; Setting in which the study was conducted; Findings which indicate a high number of...

  • Exposure rates to hepatitis C and G virus infections among HIV-infected patients: evidence of efficient transmission of HGV by the sexual route. Ramia, S.; Mokhbat, J.; Sibai, A.; Klayme, S.; Naman, R. // International Journal of STD & AIDS;Jul2004, Vol. 15 Issue 7, p463 

    The importance of sexual transmission in the epidemiology of hepatitis G virus (HGV) and hepatitis C virus (HCV) was evaluated in two groups of HIV-1-positive Lebanese patients. Members of one group (90 patients) were HIV-1-infected via sexual route and denied intravenous drug (IVD) use, while...

  • Reply. Rimland, David; Guest, Jodie L.; Marston, Barbara // Clinical Infectious Diseases;2/1/2000, Vol. 30 Issue 2, p410 

    Responds to comments on a report by C.T. Staples and colleagues, which dealt with hepatitis C virus coinfection. HIV-infection risk factor; Prevalence of both intravenous drug abuse and hepatitis C virus infection.

  • HIV and hepatitis C among injecting drug users. Coutinho, R.A. // BMJ: British Medical Journal (International Edition);08/15/98, Vol. 317 Issue 7156, p424 

    Editorial. Reports that numerous studies from across that world have shown that injecting drug users are capable of reducing their risk behavior, in relation to preventing human immunodeficiency virus (HIV) infection. Why the reduction was unexpected among drug users; Highlights of study that...

  • Research is done time to put into action. Narine, Shari // Windspeaker;Jan2009, Vol. 26 Issue 10, p27 

    The article presents the results of the survey conducted which examines the rate of HIV infection in Prince George, British Columbia. The survey reveals high rates of HIV and hepatitis infections among Aboriginal and non-Aboriginal intravenous drug users. It highlights the factors which...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics